Hidden cost of cancer: study probes financial toxicity in sarcoma patients
NCT ID NCT07215611
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the financial stress that patients with bone or soft tissue sarcoma face after surgery. Researchers will ask 100 adults to fill out questionnaires about the costs of their cancer care and how that affects their quality of life. No new treatments are being tested; the goal is simply to understand the financial burden these patients experience.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE SARCOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Talking money with your oncologist: a new tool to ease Cancer's financial toll
- New program aims to ease financial burden for cancer patients
- New app helps cancer patients fight financial toxicity
- New study aims to predict severe side effects in cancer immunotherapy
- AI chatbot aims to ease financial burden for rural cancer patients
- Money worries weigh heavy on cancer patients, new study shows